secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2021-07-02T23:59:59+00:00
Accession:  0001493152-21-016105
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Oncotelic extends note maturity to March 2022, issues 22M warrants, CTO Park resigns
--------------------------------------------------------------------------------

- Issued $103,750 convertible promissory note to Geneva Roth Remark Holdings on June 28, 2021.
- Extended maturity of JH Darbie financing notes from June 30, 2021 to March 31, 2022.
- Issued 20M additional Oncotelic warrants to investors and 2M warrants to placement agent J.H. Darbie & Co.
- CTO Chulho Park resigned effective July 1, 2021 due to personal health; will continue as part-time consultant.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000149315221016105/0001493152-21-016105-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000149315221016105/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-016105

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer